A Causal Inference Methodology to Support Research on Osteopenia for Breast Cancer Patients
Source abstract
Abstract
Breast cancer is the most common cancer in the world. With a 5-year survival rate of over 90% for patients at the early disease stages, the management of side-effects of breast cancer treatment has become a pressing issue. Observational, real-world data such as electronic health records, insurance claims, or data from wearable devices have the potential to support research on the quality of life (QoL) of breast cancer patients (BCPs), but care must be taken to avoid errors introduced due to data quality and bias. This paper proposes a causal inference methodology for using observational data to support research on the QoL of BCPs, focusing on the osteopenia of patients undergoing treatment with aromatase inhibitors (AIs). We propose a machine learning-based pipeline to estimate the average and conditional average treatment effects (ATE and CATE). For evaluation, we develop a Structural Causal Model for the osteopenia of BCPs and rely on synthetically generated data to study the effectiveness of the proposed methodology under various data challenges. A set of studies were designed to estimate the effect of high-intensity exercise on bone mineral density loss using synthetic datasets of BCPs under AI treatment. Four observational study scenarios were evaluated, corresponding to synthetically generated data of 1000 BCPs with (a) no bias, (b) sampling bias, (c) hidden confounder bias, and (d) bias due to unobserved mediator. In all cases, evaluations were performed under both complete and missing data scenarios. In particular, machine learning-based models based on tree ensembles and neural networks achieved a lower estimation error by 23.8–51.3% and 32.4–89.3% for ATE and CATE, respectively, compared to direct estimation using sample averages. The proposed approach shows improved effectiveness in treatment effect estimation in the presence of missing values and sampling bias, compared to a “traditional” statistical analysis workflow. This suggests that the application of causal effect estimation methods for the study of BCPs’ quality of life using real-world data is promising and worth pursuing further.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone health and osteoporosis research · Health Systems, Economic Evaluations, Quality of Life · Meta-analysis and systematic reviews
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Informatics and Telematics, Harokopio University, 177-78 Athens, Greece
Instituto de Investigación Sanitaria (INCLIVA), 46010 Valencia, Spain
Funding
European Union’s Horizon 2020 research and innovation programme · project REBECCA
References (95)
Show source-provided references
1. Breast Cancer Treatment: A Review10.1001/jama.2018.19323 ↗
2. Health-related quality of life in breast cancer patients: Review of reviews from 2008 to 201810.1186/s12955-020-01591-x ↗
3. Akram, M., Iqbal, M., Daniyal, M., and Khan, A.U. (2017). Awareness and current knowledge of breast cancer. Biol. Res., 50.10.1186/s40659-017-0140-9 ↗
4. Aromatase inhibitors and breast cancer10.1111/j.1749-6632.2008.03689.x ↗
5. Cancer treatment–induced bone loss (CTIBL): State of the art and proper Management in Breast Cancer Patients on endocrine therapy10.1007/s11864-021-00835-2 ↗
6. Nikander, R., Sievänen, H., Heinonen, A., Daly, R.M., Uusi-Rasi, K., and Kannus, P. (2010). Targeted exercise against osteoporosis: A systematic review and meta-analysis for optimising bone strength throughout life. BMC Med., 8.10.1186/1741-7015-8-47 ↗
7. The current landscape in biostatistics of real-world data and evidence: Clinical study design and analysis10.1080/19466315.2021.1883474 ↗
8. Real-world evidence in pain research: A review of data sources10.3109/15360288.2014.941131 ↗
9. Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform10.1038/s41746-020-0265-z ↗
10. Pintelas, E., Livieris, I.E., Barotsis, N., Panayiotakis, G., and Pintelas, P. (2021). An autoencoder convolutional neural network framework for sarcopenia detection based on multi-frame ultrasound image slices. Proceedings 17, Proceedings of the Artificial Intelligence Applications and Innovations: 17th IFIP WG 12.5 International Conference, AIAI 2021, Hersonissos, Crete, Greece, 25–27 June 2021, Springer.
11. Observational versus experimental studies: What’s the evidence for a hierarchy?10.1602/neurorx.1.3.341 ↗
12. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data10.1097/EDE.0b013e3181a663cc ↗
13. From real-world patient data to individualized treatment effects using machine learning: Current and future methods to address underlying challenges10.1002/cpt.1907 ↗
14. Liu, F., and Panagiotakos, D. (2022). Real-world data: A brief review of the methods, applications, challenges and opportunities. BMC Med. Res. Methodol., 22.10.1186/s12874-022-01768-6 ↗
15. Data processing and analysis in real-world traditional Chinese medicine clinical data: Challenges and approaches10.1002/sim.4417 ↗
16. Causal inference using potential outcomes: Design, modeling, decisions10.1198/016214504000001880 ↗
17. Causal inference from observational data10.1111/cdoe.12231 ↗
18. Randomised controlled trials—The gold standard for effectiveness research10.1111/1471-0528.15199 ↗
19. Rothwell, P.M. (2006). Factors that can affect the external validity of randomised controlled trials. PLoS Clin. Trials, 1.10.1371/journal.pctr.0010009 ↗
20. Poor quality of reporting confounding bias in observational intervention studies: A systematic review10.1016/j.annepidem.2008.05.007 ↗
21. A survey on bias and fairness in machine learning10.1145/3457607 ↗
22. Towards Domain Generalization for ECG and EEG Classification: Algorithms and Benchmarks10.1109/TETCI.2023.3306253 ↗
23. Pearl, J. (2009). Causality, Cambridge University Press.10.1017/CBO9780511803161 ↗
24. Glymour, M., Pearl, J., and Jewell, N.P. (2016). Causal Inference in Statistics: A Primer, John Wiley & Sons.
25. Applying the structural causal model framework for observational causal inference in ecology10.1002/ecm.1554 ↗
26. Reinhold, J.C., Carass, A., and Prince, J.L. (2021). A structural causal model for MR images of multiple sclerosis. Proceedings, Part V 24, Proceedings of the Medical Image Computing and Computer Assisted Intervention—MICCAI 2021: 24th International Conference, Strasbourg, France, 27 September–1 October 2021, Springer.
27. Causal models and learning from data: Integrating causal modeling and statistical estimation10.1097/EDE.0000000000000078 ↗
28. BART: Bayesian additive regression trees10.1214/09-AOAS285 ↗
29. Bayesian backfitting (with comments and a rejoinder by the authors10.1214/ss/1009212815 ↗
30. Metalearners for estimating heterogeneous treatment effects using machine learning10.1073/pnas.1804597116 ↗
31. Alaa, A., and Schaar, M. (2018, January 10–15). Limits of estimating heterogeneous treatment effects: Guidelines for practical algorithm design. Proceedings of the International Conference on Machine Learning, PMLR, Stockholm, Sweden.
32. Shalit, U., Johansson, F.D., and Sontag, D. (2017, January 6–11). Estimating individual treatment effect: Generalization bounds and algorithms. Proceedings of the 34th International Conference on Machine Learning, Sydney, Australia.
33. Villani, C. (2009). Optimal Transport: Old and New, Springer.10.1007/978-3-540-71050-9 ↗
34. A kernel two-sample test
35. Shi, C., Blei, D., and Veitch, V. (2019, January 8–14). Adapting neural networks for the estimation of treatment effects. Proceedings of the Advances in Neural Information Processing Systems 32, Vancouver, BC, Canada.
36. Kiriakidou, N., and Diou, C. (2022). An improved neural network model for treatment effect estimation. Proceedings, Part I, Proceedings of the Artificial Intelligence Applications and Innovations: 18th IFIP WG 12.5 International Conference, AIAI 2022, Hersonissos, Crete, Greece, 17–20 June 2022, Springer.
37. Kiriakidou, N., and Diou, C. (2023). Integrating nearest neighbors on neural network models for treatment effect estimation. Int. J. Neural Syst., 33.10.1142/S0129065723500363 ↗
38. Intake monitoring in free-living conditions: Overview and lessons we have learned10.1016/j.appet.2022.106096 ↗
39. A data driven end-to-end approach for in-the-wild monitoring of eating behavior using smartwatches10.1109/JBHI.2020.2984907 ↗
40. Sarafis, I., Diou, C., and Delopoulos, A. (2019, January 23–27). Behaviour profiles for evidence-based policies against obesity. Proceedings of the 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Berlin, Germany.10.1109/EMBC.2019.8857161 ↗
41. A generalization and Bayesian interpretation of ridge-type estimators with good prior means10.1007/BF02924684 ↗
42. Discriminatory analysis. Nonparametric discrimination: Consistency properties10.2307/1403797 ↗
43. Random forests10.1023/A:1010933404324 ↗
44. Extremely randomized trees10.1007/s10994-006-6226-1 ↗
45. Liu, F.T., Ting, K.M., and Zhou, Z.H. (2008, January 15–19). Isolation forest. Proceedings of the 2008 Eighth IEEE International Conference on Data Mining, Pisa, Italy.10.1109/ICDM.2008.17 ↗
46. Breunig, M.M., Kriegel, H.P., Ng, R.T., and Sander, J. (2000, January 15–18). LOF: Identifying density-based local outliers. Proceedings of the 2000 ACM SIGMOD International Conference on Management of Data, Dallas, TX, USA.10.1145/342009.335388 ↗
47. Estimating the support of a high-dimensional distribution10.1162/089976601750264965 ↗
48. T-scores and Z-scores10.1007/s12018-009-9064-4 ↗
49. Population-level management of type 1 diabetes via continuous glucose monitoring and algorithm-enabled patient prioritization: Precision health meets population health10.1111/pedi.13256 ↗
50. Teamwork, targets, technology, and tight control in newly diagnosed type 1 diabetes: The pilot 4T study10.1210/clinem/dgab859 ↗
51. Advancements and future directions in the teamwork, targets, technology, and tight control—The 4T study: Improving clinical outcomes in newly diagnosed pediatric type 1 diabetes10.1097/MOP.0000000000001140 ↗
52. Aromatase inhibitors in breast cancer10.1056/NEJMra023246 ↗
53. Aromatase inhibitors in the treatment of breast cancer10.1210/er.2004-0015 ↗
54. DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data10.1016/j.artmed.2014.11.003 ↗
55. Integrative blockwise sparse analysis for tissue characterization and classification10.1016/j.artmed.2020.101885 ↗
56. Amkrane, Y., El Adoui, M., and Benjelloun, M. (2020, January 24–26). Towards breast cancer response prediction using artificial intelligence and radiomics. Proceedings of the 2020 5th International Conference on Cloud Computing and Artificial Intelligence: Technologies and Applications (CloudTech), Marrakesh, Morocco.10.1109/CloudTech49835.2020.9365890 ↗
57. Shaikh, K., Krishnan, S., and Thanki, R.M. (2021). Artificial Intelligence in Breast Cancer Early Detection and Diagnosis, Springer.10.1007/978-3-030-59208-0 ↗
58. Louizos, C., Shalit, U., Mooij, J.M., Sontag, D., Zemel, R., and Welling, M. (2017, January 4–9). Causal effect inference with deep latent-variable models. Proceedings of the Advances in Neural Information Processing Systems, Long Beach, CA, USA.
59. Mutual information-based neighbor selection method for causal effect estimation10.1007/s00521-024-09555-8 ↗
60. Montgomery, D.C., Peck, E.A., and Vining, G.G. (2021). Introduction to Linear Regression Analysis, John Wiley & Sons.
61. The Role of High-intensity and High-impact Exercises in Improving Bone Health in Postmenopausal Women: A Systematic Review
62. Effect of weighted exercises on bone mineral density in post menopausal women a systematic review10.1519/00139143-200708000-00007 ↗
63. Effects of the physical activity on the bone mineral density and bone remodelation10.1590/S1517-86922005000600013 ↗
64. A novel test of missing completely at random: U-statistics-based approach10.1080/02331888.2024.2386361 ↗
65. Barata, A.P., Takes, F.W., van den Herik, H.J., and Veenman, C.J. (2019, January 8–11). Imputation methods outperform missing-indicator for data missing completely at random. Proceedings of the 2019 International Conference on Data Mining Workshops (ICDMW), Beijing, China.10.1109/ICDMW.2019.00066 ↗
66. A novel forecasting strategy for improving the performance of deep learning models10.1016/j.eswa.2023.120632 ↗
67. High-intensity exercise and geometric indices of hip bone strength in postmenopausal women on or off bone medication: The MEDEX-OP randomised controlled trial10.1007/s00223-022-00991-z ↗
68. Clinician’s guide to prevention and treatment of osteoporosis10.1007/s00198-014-2794-2 ↗
69. Kiriakidou, N., Livieris, I.E., and Diou, C. (2024, January 27–30). C-XGBoost: A tree boosting model for causal effect estimation. Proceedings of the IFIP International Conference on Artificial Intelligence Applications and Innovations, Corfu, Greece.10.1007/978-3-031-63219-8_5 ↗
70. A review of the role of estrogen in dermal aging and facial attractiveness in women10.1111/jocd.12508 ↗
71. Pathogenesis of age-related bone loss in humans
72. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
73. Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?10.1093/jnci/djw147 ↗
74. Calcitonin and estrogens10.1007/BF03349583 ↗
75. The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study10.1016/S1475-4916(03)00035-3 ↗
76. The effect of estrogen replacement therapy on visceral fat, serum glucose, lipid profiles and apelin level in ovariectomized rats10.6118/jmm.2017.23.3.182 ↗
77. Gava, G., Orsili, I., Alvisi, S., Mancini, I., Seracchioli, R., and Meriggiola, M.C. (2019). Cognition, mood and sleep in menopausal transition: The role of menopause hormone therapy. Medicina, 55.10.3390/medicina55100668 ↗
78. Estrogen effects on cognitive and synaptic health over the lifecourse10.1152/physrev.00036.2014 ↗
79. Studd, J. (1994). Estrogens and depression in women. Women’s Health in Menopause: Behaviour, Cancer, Cardiovascular Disease, Hormone Replacement Therapy, Springer.10.1007/978-94-011-1024-2_26 ↗
80. Exercisers achieve greater acute exercise-induced mood enhancement than nonexercisers10.1016/j.apmr.2007.09.026 ↗
81. Exercise and fatigue10.2165/00007256-200939050-00005 ↗
82. Association between sleep disorders, obesity, and exercise: A review10.2147/NSS.S34838 ↗
83. Aerobic exercise in severe mental illness: Requirements from the perspective of sports medicine10.1007/s00406-021-01360-x ↗
84. The association between physical activity and hot flash severity, frequency, and duration in mid-life women10.1002/ajhb.20834 ↗
85. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: A couple’s problem–2003 update10.4158/EP.9.1.77 ↗
86. Exercise for depression
87. Gombos, G.C., Bajsz, V., Pék, E., Schmidt, B., Sió, E., Molics, B., and Betlehem, J. (2016). Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass. BMC Musculoskelet. Disord., 17.10.1186/s12891-016-1109-5 ↗
88. Evidence for calcitonin—a new hormone from the parathyroid that lowers blood calcium10.1210/endo-70-5-638 ↗
89. Vitamin D: More than just affecting calcium and bone10.1007/s11926-005-0020-0 ↗
90. Moderate alcohol consumption and urinary excretion of magnesium and calcium10.1080/003655101316911459 ↗
91. Vitamin D and type 2 diabetes: A systematic review10.1038/ejcn.2011.118 ↗
92. Calcium orthophosphates10.1007/s10853-006-1467-8 ↗
93. The impact of smoking on bone metabolism, bone mineral density and vertebral fractures in postmenopausal women10.1016/j.jocd.2019.07.007 ↗
94. Bone resorption in tissue culture. Factors influencing the response to parathyroid hormone10.1172/JCI105117 ↗
95. Comparison of analytical performance and biological variability of three bone resorption assays10.1093/clinchem/43.9.1570 ↗